These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36369514)

  • 41. Ultrastructural studies of bones from patients with osteogenesis imperfecta.
    Traub W; Arad T; Vetter U; Weiner S
    Matrix Biol; 1994 Aug; 14(4):337-45. PubMed ID: 7827757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors.
    Nudelman F; Pieterse K; George A; Bomans PH; Friedrich H; Brylka LJ; Hilbers PA; de With G; Sommerdijk NA
    Nat Mater; 2010 Dec; 9(12):1004-9. PubMed ID: 20972429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype.
    Sarathchandra P; Pope FM; Kayser MV; Ali SY
    J Pathol; 2000 Nov; 192(3):385-95. PubMed ID: 11054723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Collagen fibrils of osteoid in osteogenesis imperfecta: morphometrical analysis of the fibril diameter.
    Stöss H; Freisinger P
    Am J Med Genet; 1993 Jan; 45(2):257. PubMed ID: 8456812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical localization of interstitial collagens in bone tissue from patients with various forms of osteogenesis imperfecta.
    Nerlich AG; Brenner RE; Wiest I; Lehmann H; Yang C; Müller PK; von der Mark K
    Am J Med Genet; 1993 Jan; 45(2):258-9. PubMed ID: 8456813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Molecular Weight and Concentration of Poly(Acrylic Acid) on Biomimetic Mineralization of Collagen.
    Qi Y; Ye Z; Fok A; Holmes BN; Espanol M; Ginebra MP; Aparicio C
    ACS Biomater Sci Eng; 2018 Aug; 4(8):2758-2766. PubMed ID: 30581990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
    Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
    J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
    Lindahl K; Barnes AM; Fratzl-Zelman N; Whyte MP; Hefferan TE; Makareeva E; Brusel M; Yaszemski MJ; Rubin CJ; Kindmark A; Roschger P; Klaushofer K; McAlister WH; Mumm S; Leikin S; Kessler E; Boskey AL; Ljunggren O; Marini JC
    Hum Mutat; 2011 Jun; 32(6):598-609. PubMed ID: 21344539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A morphometric analysis of osteoid collagen fibril diameter in osteogenesis imperfecta.
    Cassella JP; Barber P; Catterall AC; Ali SY
    Bone; 1994; 15(3):329-34. PubMed ID: 8068454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.
    Sinder BP; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
    Bone; 2015 Feb; 71():115-23. PubMed ID: 25445450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type V osteogenesis imperfecta: a new form of brittle bone disease.
    Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
    J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiscale structural evolution of citrate-triggered intrafibrillar and interfibrillar mineralization in dense collagen gels.
    Jiang W; Griffanti G; Tamimi F; McKee MD; Nazhat SN
    J Struct Biol; 2020 Oct; 212(1):107592. PubMed ID: 32736073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I.
    Liu Y; Wang J; Liu S; Kuang M; Jing Y; Zhao Y; Wang Z; Li G
    Bone; 2019 Oct; 127():646-655. PubMed ID: 31369917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promotion effect of immobilized chondroitin sulfate on intrafibrillar mineralization of collagen.
    He H; Shao C; Mu Z; Mao C; Sun J; Chen C; Tang R; Gu X
    Carbohydr Polym; 2020 Feb; 229():115547. PubMed ID: 31826527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defective association between collagen fibrils and proteoglycans in fragile bone of osteogenesis imperfecta.
    Nogami H; Oohira A
    Clin Orthop Relat Res; 1988 Jul; (232):284-91. PubMed ID: 3383494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A morphological and ultrastructural study of bone in osteogenesis imperfecta.
    Cassella JP; Stamp TC; Ali SY
    Calcif Tissue Int; 1996 Mar; 58(3):155-65. PubMed ID: 8852570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. STMP and PVPA as Templating Analogs of Noncollagenous Proteins Induce Intrafibrillar Mineralization of Type I Collagen via PCCP Process.
    Wang Y; Zhang Y; Shen Z; Qiu Y; Wang C; Wu Z; Shen M; Shao C; Tang R; Hannig M; Fu B; Zhou Z
    Adv Healthc Mater; 2024 Apr; ():e2400102. PubMed ID: 38657167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Four patients with Sillence type I osteogenesis imperfecta and mild bone fragility, complicated by left ventricular cardiac valvular disease and cardiac tissue fragility caused by type I collagen mutations.
    Vandersteen AM; Lund AM; Ferguson DJ; Sawle P; Pollitt RC; Holder SE; Wakeling E; Moat N; Pope FM
    Am J Med Genet A; 2014 Feb; 164A(2):386-91. PubMed ID: 24311407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.